Australia Markets closed

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5911-0.0239 (-3.89%)
At close: 04:00PM EDT
0.5951 +0.00 (+0.68%)
After hours: 07:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.11
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 37.3600
52-week low 30.2900
50-day moving average 30.8476
200-day moving average 30.8921

Share statistics

Avg vol (3-month) 33.57M
Avg vol (10-day) 3701.09k
Shares outstanding 557.54M
Implied shares outstanding 6N/A
Float 853.46M
% held by insiders 10.05%
% held by institutions 117.36%
Shares short (12 Jan 2023) 45.66M
Short ratio (12 Jan 2023) 40.73
Short % of float (12 Jan 2023) 49.84%
Short % of shares outstanding (12 Jan 2023) 49.83%
Shares short (prior month 14 Dec 2022) 44.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 331 Oct 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.74%
Return on equity (ttm)-50.14%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -108.4M
Net income avi to common (ttm)-112.35M
Diluted EPS (ttm)-0.5520
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.98M
Total cash per share (mrq)2.43
Total debt (mrq)886k
Total debt/equity (mrq)0.39
Current ratio (mrq)11.33
Book value per share (mrq)0.43

Cash flow statement

Operating cash flow (ttm)-98.2M
Levered free cash flow (ttm)-123.75M